SCHEMBL5377652

SCHEMBL5377652

CCCCc1cc(N)ccc1CCc1ccc(N)cc1CCCC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 2/20 0.46
TLR8 Q9NR97 2/20 0.42
PRKCI P41743 1/20 0.40
SKP2 Q13309 1/20 0.40
TSHR P16473 3/20 0.39
MAPT P10636 3/20 0.39
HTT P42858 2/20 0.39
ACHE P22303 1/20 0.39
MEN1 O00255 1/20 0.39
TP53 P04637 1/20 0.39
CYP3A4 P08684 1/20 0.39
ALOX5 P09917 1/20 0.39
ALOX15 P16050 1/20 0.39
KMT2A Q03164 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
GAA P10253 1/20 0.38
MAPK1 P28482 1/20 0.38
CTRC Q99895 1/20 0.38
GABRP O00591 1/20 0.37
GABRD O14764 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11347930 0.98 TYR (0.47) TYRTLR8PRKCISKP2TSHR
SCHEMBL25144469 0.94 TYR (0.44) TYRTLR8PRKCISKP2TSHR
SCHEMBL5379403 0.94 TYR (0.46) TYRTLR8PRKCITSHRMAPT
SCHEMBL5377545 0.92 MAPT (0.49) TYRTLR8TSHRMAPTHTT
SCHEMBL6835567 0.92 TYR (0.47) TYRTLR8PRKCITSHRMAPT
SCHEMBL22271585 0.90 TYR (0.44) TYRTLR8PRKCISKP2TSHR
SCHEMBL23864412 0.90 TYR (0.44) TYRTLR8PRKCISKP2TSHR
SCHEMBL5377939 0.87 PRKCI (0.42) TLR8PRKCITSHRMAPTHTT
SCHEMBL27705879 0.85 SLC6A4 (0.43) TYRTLR8PRKCISKP2TSHR
SCHEMBL4576433 0.85 PRKCI (0.44) TLR8PRKCITSHRMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202359-B2 Azaoxa heterocyclic compound and method of preparing the same CHANG CHUN PLASTICS CO., LTD. (TW) 2007-04-10 US disclosed
US-20050085634-A1 Azaoxa heterocyclic compound and method of preparing the same CHANG CHUN PLASTICS CO., LTD. (TW) 2005-04-21 US disclosed
US-20040068084-A1 Azaoxa heterocyclic compound and method of preparing the same CHANG CHUN PLASTICS CO., LTD. (TW) 2004-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040068084-A1 Azaoxa heterocyclic compound and method of preparing the same AOX1, KDM1A, BMI1 TYR 485/4885TLR8 4587/4885PRKCI 4739/4885
US-20050085634-A1 Azaoxa heterocyclic compound and method of preparing the same AOX1, KDM1A, BMI1 TYR 314/4885TLR8 4563/4885PRKCI 4722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.